HIGHLIGHTS
- What: The aim of this study is to evaluate the impact of adding PET/CT to CT and MRI imaging for clinical target volume (CTV) definition for proton therapy treatment planning for benign skull base tumors with SSTR2 receptor expression.
- Who: Carola Lütgendorf-Caucig et al. from the MedAustron Ion Therapy Center, Wiener Neustadt, Austria, Department of Radiation Oncology, Heidelberg University Hospital have published the article: The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study, in the Journal: (JOURNAL)
- How: The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.